Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Analytical Biochemistry

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABIO.1999.4413PMID 10640350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53

  1999cited by this paper
• Covalent and noncovalent modifiers of the p53 protein

  1999cited by this paper
• MDM2 Suppresses p73 Function without Promoting p73 Degradation

  1999cited by this paper
• Functions of the MDM2 oncoprotein

  1999cited by this paper
• p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage

  1999cited by this paper
• The emerging p53 gene family.

  1999cited by this paper
• Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.

  1999cited by this paper
• Use of a phosphotyrosine-antibody pair as a general detection method in homogeneous time-resolved fluorescence: application to human immunodeficiency viral protease.

  1999cited by this paper
• A role for ATR in the DNA damage-induced phosphorylation of p53.

  1999cited by this paper
• Regulation of p53 Function and Stability by Phosphorylation

  1999cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Development of a CD28/CD86 (B7-2) Binding Assay for High Throughput Screening by Homogeneous Time-Resolved Fluorescence

  1998cited by this paper
• Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73

  1998cited by this paper
• Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

  1998cited by this paper
• DNA damage activates p53 through a phosphorylation-acetylation cascade.

  1998cited by this paper
• Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

  1998cited by this paper
• Signaling to p53: breaking the MDM2-p53 circuit.

  1998cited by this paper
• Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence

  1998cited by this paper
• Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.

  1997cited by this paper
• p73 is a simian [correction of human] p53-related protein that can induce apoptosis.

  1997cited by this paper
• Molecular characterization of the hdm2-p53 interaction.

  1997cited by this paper
• Repression of p53-mediated transcription by MDM2: a dual mechanism.

  1997cited by this paper
• p73 is a human p53-related protein that can induce apoptosis

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• In vivo ubiquitination and proteasome-mediated degradation of p53(1).

  1996cited by this paper
• Identification of novel mdm2 binding peptides by phage display.

  1996cited by this paper
• Use of a Novel Homogeneous Fluorescent Technology in High Throughput Screening

  1996cited by this paper
• Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

  1996cited by this paper
• Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer.

  1995cited by this paper
• Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

  1994cited by this paper
• Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli

  1993cited by this paper

• KRAS4b:RAF-1 Homogenous Time-Resolved Fluorescence Resonance Energy Transfer Assay for Drug Discovery.

  2024cites this paper
• Using Förster Resonance Energy Transfer (FRET) to Understand the Ubiquitination Landscape

  2024cites this paper
• Structural basis for α-helix mimicry and inhibition of protein-protein interactions with oligourea foldamers.

  2020cites this paper
• The C-terminal SAM domain of p73 binds to the N terminus of MDM2.

  2019cites this paper
• Method for screening of UBC12/Dcn1 small molecule inhibitor by HTRF technology

  2017cites this paper
• C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells.

  2013cites this paper
• Studies of G Protein-Coupled Receptor Stability and Dimerization Using Novel Fluorescence and Crosslinking Approaches

  2013cites this paper
• Two high-throughput screening assays for aberrant RNA–protein interactions in myotonic dystrophy type 1

  2012cites this paper
• Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins.

  2012cites this paper
• Using lanthanide-based resonance energy transfer for in vitro and in vivo studies of biological processes

  2012cites this paper
• Fluorescence resonance energy transfer between fluorescent proteins as powerful toolkits for in vivo studies

  2011cites this paper
• Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands.

  2011cites this paper
• Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors.

  2011cites this paper
• The C terminus of p 53 binds the N-terminal domain of MDM 2

  2010cites this paper
• The C-terminus of p53 binds the N-terminal domain of MDM2

  2010cites this paper
• Genetically encoded FRET-pair on the basis of terbium-binding peptide and red fluorescent protein

  2010cites this paper
• Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.

  2010cites this paper
• A homogeneous time-resolved fluoroimmunoassay (TR-FIA) using antibody mediated luminescence quenching

  2010cites this paper
• Fluorescence resonance energy transfer studies of protein interactions

  2008cites this paper
• Targeting the p53/MDM2 Pathway for Cancer Therapy

  2008cites this paper
• The BRET technology and its application to screening assays

  2008cites this paper
• High-throughput screening assays for the identification of chemical probes.

  2007cites this paper
• Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX

  2007cites this paper
• Recommendations for the Reduction of Compound Artifacts in Time-Resolved Fluorescence Resonance Energy Transfer Assays

  2007cites this paper
• Homogeneous indirect fluorescence quenching immunoassay for the determination of low molecular weight substances

  2006cites this paper
• HTRF®: pioneering technology for high-throughput screening

  2006cites this paper
• SWTY--a general peptide probe for homogeneous solution binding assay of 14-3-3 proteins.

  2006cites this paper
• A homogeneous FRET assay system for multiubiquitin chain assembly and disassembly.

  2005cites this paper
• Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase.

  2005cites this paper
• Extra Views A New Twist in the Feedback Loop Stress-Activated MDM 2 Destabilization is Required for p 53 Activation

  2005cites this paper
• A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation

  2005cites this paper
• Protein Interactions Studied by Biochemical and NMR Spectroscopic Methods

  2004cites this paper
• Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface.

  2004cites this paper
• Inhibiting the p53–MDM2 interaction: an important target for cancer therapy

  2003cites this paper
• Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin.

  2003cites this paper
• Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation

  2003cites this paper
• The N-terminal domain of p53 is natively unfolded.

  2003cites this paper
• Homogeneous Time Resolved Fluorescence ( HTRF ) – A Reference Technology Dedicated to Drug Screening

  2003cites this paper
• Fluorescence resonance energy transfer in the study of cancer pathways

  2003cites this paper
• CHAPTER 14 – MECHANISM-BASED HIGH-THROUGHPUT SCREENING FOR NOVEL ANTICANCER DRUG DISCOVERY

  2002cites this paper
• Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions.

  2002cites this paper
• Apoptosis and the treatment of breast cancer

  2002cites this paper
• Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract.

  2002cites this paper
• Real-time background suppression during frequency domain lifetime measurements.

  2002cites this paper
• Developments in fluorescence lifetime-based analysis for ultra-HTS

  2001cites this paper
• Time-Resolution in Fluorometry Technologies, Labels, and Applications in Bioanalytical Assays

  2001cites this paper
• Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein

  2001cites this paper
• Signaling pathways in apoptosis as potential targets for cancer therapy.

  2001cites this paper
• Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as a tool for probing molecular interactions in biology.

  2001cites this paper
• A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer.

  2001cites this paper
• Interaction between heat shock proteins and antimicrobial peptides.

  2000cites this paper
• Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length.

  2000cites this paper
• INHIBITING THE p 53 – MDM 2 INTERACTION : AN IMPORTANT TARGET FOR CANCER THERAPY

  year unknowncites this paper